Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
Want to see MLYS full AI Analyst Report?
Mineralys Therapeutics, Inc. (MLYS) Ownership Overview
27.04% Insiders
17.84% Mutual Funds
23.36% Other Institutional Investors
9.88% ETFs
21.88% Public Companies and
Individual Investors
The ownership structure of Mineralys Therapeutics, Inc. (MLYS) stock is a mix of institutional, retail, and individual investors. Approximately 51.08% of the company’s stock is owned by Institutional Investors, 27.04% is owned by Insiders, and 21.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $8762797 | |
Nov 21, 2025 | xxxxxxxxxxxxx | $43350000 | |
Nov 13, 2025 | xxxxxxxxxxxxx | $689687 | |
Nov 13, 2025 | xxxxxxxxxxxxx | $1575976 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $208396598 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,910,038 | Insider | 9.59% | 249,166,197 | |
| 7,692,750 | Institution | 9.32% | 242,321,625 | |
| 7,692,750 | Insider | 9.32% | 242,321,625 | |
| 5,877,218 | Insider | 7.12% | 185,132,367 | |
| 2,847,236 | Institution | 3.45% | 89,687,934 | |
| 2,451,814 | Institution | 2.97% | 77,232,141 | |
| 2,390,002 | Institution | 2.90% | 75,285,063 | |
| 2,060,657 | Institution | 2.50% | 64,910,696 | |
| 1,421,700 | Institution | 1.72% | 44,783,550 | |
| 1,215,766 | Institution | 1.47% | 38,296,629 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,390,002 | Institution | 2.90% | 75,285,063 | |
| 1,421,700 | Institution | 1.72% | 44,783,550 | |
| 1,215,766 | Institution | 1.47% | 38,296,629 | |
| 806,800 | Institution | 0.98% | 25,414,200 | |
| 801,499 | Institution | 0.97% | 25,247,219 | |
| 713,061 | Institution | 0.86% | 22,461,422 | |
| 623,239 | Institution | 0.76% | 19,632,029 | |
| 566,622 | Institution | 0.69% | 17,848,593 | |
| 523,132 | Institution | 0.63% | 16,478,658 | |
| 496,754 | Institution | 0.60% | 15,647,751 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,962,599 | Institution | 2.38% | 58,348,068 | |
| 1,774,478 | Institution | 2.15% | 48,070,609 | |
| 1,110,999 | Institution | 1.35% | 32,507,831 | |
| 620,531 | Institution | 0.75% | 16,810,185 | |
| 435,078 | Institution | 0.53% | 12,730,382 | |
| 392,771 | Institution | 0.48% | 11,492,479 | |
| 271,725 | Institution | 0.33% | 8,078,384 | |
| 234,976 | Institution | 0.28% | 6,365,500 | |
| 136,234 | Institution | 0.17% | 3,690,579 | |
| 121,879 | Institution | 0.15% | 3,566,180 |
FAQ
Who Owns Mineralys Therapeutics, Inc. (MLYS)?
According to the latest TipRanks data, approximately 23.36% of the company's stock is held by institutional investors, 27.04% is held by insiders, and 21.88% is held by retail investors.
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 23.36% of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors.
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.88% of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors.
Who owns the most shares of Mineralys Therapeutics, Inc. (MLYS)?
Brian Taylor Slingsby owns the most shares of Mineralys Therapeutics, Inc. (MLYS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.